CRCP
WST icon

Copper Rock Capital Partners’s West Pharmaceutical WST Stock Holding History

Copper Rock Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-343,878
Closed -$28.2M – 106
2017
Q1 		$28.2M Buy
343,878
+5,795
+2% +$485K 1.78% 27
2016
Q4 		$28.7M Sell
338,083
-2,640
-0.8% -$208K 1.84% 22
2016
Q3 		$25.1M Sell
340,723
-3,124
-0.9% -$248K 1.63% 26
2016
Q2 		$26.1M Buy
343,847
+5,322
+2% +$387K 1.98% 18
2016
Q1 		$23.5M Sell
338,525
-1,390
-0.4% -$83.6K 2.01% 23
2015
Q4 		$20.5M Sell
339,915
-205,851
-38% -$12.4M 1.7% 35
2015
Q3 		$29.5M Sell
545,766
-174,668
-24% -$10.2M 2.5% 13
2015
Q2 		$41.8M Buy
720,434
+87,801
+14% +$4.9M 3.1% 3
2015
Q1 		$38.1M Buy
632,633
+69,058
+12% +$3.68M 3.12% 4
2014
Q4 		$30M Buy
563,575
+38,501
+7% +$1.93M 2.78% 7
2014
Q3 		$23.5M Buy
525,074
+152,245
+41% +$6.47M 2.57% 8
2014
Q2 		$15.7M Sell
372,829
-190,694
-34% -$8.17M 2.5% 13
2014
Q1 		$24.8M Buy
563,523
+38,730
+7% +$1.82M 2.44% 2
2013
Q4 		$25.7M Buy
524,793
+1,741
+0.3% +$81.5K 2.52% 1
2013
Q3 		$21.5M Sell
523,052
-34,340
-6% -$1.31M 2.3% 2
2013
Q2 		$19.6M Buy
+557,392
New +$18.3M 2.11% 2

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Copper Rock Capital Partners's WST Position: Q2 2017 in Review

Copper Rock Capital Partners sold out of West Pharmaceutical (WST) in Q2 2017, closing a stake of 343,878 shares — an estimated $28.2M sold.

Copper Rock Capital Partners first reported a position in WST in Q2 2013 and held it in 16 quarters. The position peaked at $41.8M in Q2 2015. 309 funds tracked by Wall St. Rank hold WST as of Q2 2017.

  • Copper Rock Capital Partners reported no remaining West Pharmaceutical position as of Q2 2017 after selling out during the quarter.
  • Copper Rock Capital Partners sold 343,878 West Pharmaceutical shares in Q2 2017, an estimated $28.2M.
  • Copper Rock Capital Partners first reported a position in West Pharmaceutical in Q2 2013 and held it in 16 quarters.
  • Copper Rock Capital Partners's West Pharmaceutical position peaked at $41.8M in Q2 2015.
  • 309 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Copper Rock Capital Partners's 13F filing for Q2 2017, filed 6 Jul 2017.